US 8993633
Treatment of muscle disease characterized by insulin resistance
granted A61KA61K31/155A61P
Quick answer
US patent 8993633 (Treatment of muscle disease characterized by insulin resistance) held by Fate Therapeutics, (Canada) Inc. expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, (Canada) Inc.
- Grant date
- Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/155, A61P, A61P21/00